Optimi Health Corp. announced the appointment of Chief Science Officer, Mr. Justin Kirkland, to the PIR Medical & Clinical Advisory Board. Justin will join a team of leading experts in the development of treatment protocols, identify research priorities, and help form the broader group of advisors and on site medical team.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 CAD | +5.00% | +10.53% | +71.43% |
22/05 | Optimi Health to Be Sole Supplier of Psilocybin for ATMA Journey Centers Phase II Trial | MT |
14/05 | Optimi Health Receives Certificate of Analysis for Mdma 40Mg and 60Mg Gmp Capsules | CI |
1st Jan change | Capi. | |
---|---|---|
+71.43% | 2.66Cr | |
-.--% | 84Cr | |
+2.36% | 69Cr | |
+30.94% | 48Cr | |
+20.97% | 25Cr | |
0.00% | 13Cr | |
+113.04% | 5.94Cr |
- Stock Market
- Equities
- OPTI Stock
- News Optimi Health Corp.
- Optimi Health Corp. Appoints Justin Kirkland as Chief Science Officer